US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Monopar Therapeutics Inc (MNPR)
Monopar Therapeutics Inc (MNPR) ニュース

MNPR

Monopar Therapeutics (MNPR)

Monopar Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MNPR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/18	07 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/11	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/11	20 : 30	GlobeNewswire Inc.	Monopar and NorthStar Amend & Extend Collaboration	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/10	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/10	21 : 00	GlobeNewswire Inc.	Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/06	07 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/01	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/31	07 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/25	05 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/24	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/24	21 : 00	GlobeNewswire Inc.	Monopar Announces CFO Succession	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/09	20 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/09	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/09	20 : 00	GlobeNewswire Inc.	Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/04/18	21 : 00	GlobeNewswire Inc.	Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/04/16	21 : 00	GlobeNewswire Inc.	Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/04/10	21 : 00	GlobeNewswire Inc.	Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/28	20 : 00	GlobeNewswire Inc.	Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/07	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/05	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/05	21 : 00	GlobeNewswire Inc.	Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/29	03 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/27	21 : 00	GlobeNewswire Inc.	Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/27	20 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/22	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/22	21 : 00	GlobeNewswire Inc.	Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/20	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/20	22 : 00	GlobeNewswire Inc.	Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/01/04	09 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/01/04	09 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:MNPR

1 2 3 4 5 6 7 8 9 10 次へ >>

Purple Storm 2016 BV Flo...

Hub Cyber Security

BNP Paribas Issuance

Abertis Infraestructuras

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約